DIAGNOSTIC METHOD FOR MYOFIBROBLASTIC DISEASE

PROBLEM TO BE SOLVED: To provide a diagnostic method for arteriosclerosis by finding out a causative substance of the arteriosclerosis onset, and measuring the causative substance, and provide a diagnostic method for myofibroblastic disease other than the arteriosclerosis. SOLUTION: This diagnostic...

Full description

Saved in:
Bibliographic Details
Main Authors SOFUE KENJI, HAYASHI KENICHIRO
Format Patent
LanguageEnglish
Published 21.02.2003
Edition7
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PHYSICS
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
TESTING
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide a diagnostic method for arteriosclerosis by finding out a causative substance of the arteriosclerosis onset, and measuring the causative substance, and provide a diagnostic method for myofibroblastic disease other than the arteriosclerosis. SOLUTION: This diagnostic method for myofibroblastic disease is characterized by measuring unsaturated lysophosphatidic acid(LPA) in a sample.
Bibliography:Application Number: JP20010154521